Current Grants and Contracts

Pharmacological Management of Pain in Alzheimer’s Disease and Related Dementia

Principal investigator: Yu-Jung Wei
Study period: 08/2017-05/2022
Funding agency: IoA

Improving Causal Inference via New Statistical Learning Methods with High Dimensional Data

Principal investigator: Almut Winterstein
Study period: 07/2016-10/2020
Funding agency: PCORI
This study will exploit several novel ideas, based on combining inverse probability weighing and machine learning techniques, to systematically address various open issues associated with model building and estimation, learning algorithm, and parameter regularization. It will evaluate and compare the performances of new and existing methods, using both simulations and empirical data from ongoing pharmacoepidemiological studies.

The Child Health Quality (CHeQ) Partnership Program

Principal investigator: Shenkman Co-Investigator: Almut Winterstein
Study period: 09/30/2016 – 09/29/2020
Funding agency: Agency for Healthcare Research and Quality
This study will test the feasibility and usability of children quality of care measure sets through field testing and translating results into QI goals and multi-level performance improvement projects. In addition, it will implement and disseminate leading-edge methods to evaluate and compare quality of care at multiple levels, including the state, health plan, and provider levels.

LIFE’s Legacy (Pepper Junior Scholars Program)

Principal investigator: Joshua Brown
Study period: 04/01/2017-03/30/2019
Funding agency: NIA, UF-IoA

Comparative Effectiveness of Direct-Acting Oral Anticoagulants (DOACs) for Stroke

Principal investigator: Joshua Brown
Study period: 2018
Funding agency: PhRMA Foundation

Inpatient Psychiatric Facility Outcome and Process Measure Development and Maintenance

Principal investigator: Winterstein (20%) for UF/UF Health, Subcontract with Health Service Advisory Group
Study period: 09/30/2014-09/29/2018
Funding agency: Centers for Medicare and Medicaid Services
This contract will support the development and validation of eight new performance measures for inpatient psychiatric facilities along with the maintenance of existing measures.

Community Health Workers Practice Improvements

Principal investigator: Richard Segal
Study period: 07/2017-06/2018
Funding agency: FLDOH/CDC

Genomic Medicine Implementation: The Personalized Medicine Program

Principal investigator: JA Johnson Co-Investigator: Almut Winterstein
Study period: 09/07/2017-04/30/2018
Funding agency: NIH/NHGRI
The purpose of the main administrative supplement request is the seek funding to advance a variety of cross network analyses and projects that should significantly advance pharmacogenomics implementation and the IGNITE network. The other three administrative supplements are to continue our leadership in the Pharmacogenetics Working Group, the Provider Adoption, Barriers, and Education Working Group and the IGNITE website.

All-Cause Readmission Measures on Inpatient Psychiatry Facilities

Principal investigator: Rene Soria-Saucedo
Study period: 03/03/2017-03/02/2018
Funding agency: Shands

Clinical and Economic Outcomes of a Digital Health Offering in a Patient Population with Cardiovascular and Metabolic Chronic Disease

Principal investigator: Haesuk Park
Study period: 06/01/2016-12/31/2017
Funding agency: Proteus Digital Health
This project will evaluate the real-world impact of a digital health offering on adherence, clinical and economic outcomes, and healthcare utilization at Barton Health.

Improving Medication Related Outcomes by Having Community Health Workers Collaborate with Pharmacist

Principal investigator: Rich Segal (Folake Odedina: Co-Principal Investigator)
Study period: 07/1/2017 – 06/30/2018
Funding agency: DOH and CDC
This Project focuses on evaluating a new practice models focusing on collaborations of community health workers and pharmacists to improve therapeutic outcomes among poorly controlled patients with hypertension and/or diabetes.

Real-time risk stratification of hypo- and hyperglycemia to enhance glucose management outcomes in hospitals

HHSF-223-2015-10118C [FDABAA-15-00121]
Principal investigator (PI):  Almut G. Winterstein (10%)
Study period: 9/30/2015-12/31/2018
Funding agency: Food and Drug Administration (FDA)
This study will evaluate the effectiveness of an EHR-based algorithm that ranks patients according to hypo- and hyperglycemia risk for pharmacist intervention in two UF Health hospitals.

Inpatient Psychiatric Facility Outcome and Process Measure Development and Maintenance

HHSM-500-2013-13007I [HHSM-500-T0004]
Principal investigator: Winterstein for UF/UF Health, Subcontract with Health Service Advisory Group
Study period: 9/30/2014-9/29/2018
Funding agency: Centers for Medicare and Medicaid Services
This contract will support the development and validation of eight new performance measures for inpatient psychiatric facilities along with the maintenance of existing measures.